A clinical trial to study the effects of transcranial magnetic stimulation for improving nerve functionsamong patients with leprosy neuritis
Not Applicable
- Conditions
- Health Condition 1: A309- Leprosy, unspecified
- Registration Number
- CTRI/2022/01/039073
- Lead Sponsor
- ovely Professional University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Clinically diagnosed leprosy patients aged between 18 to 45 years
undergoing WHO- MDT therapy with Ulnar and/or Median and/or
Ulnar neuritis of 6 months of duration and eligible for oral steroid
therapy
Exclusion Criteria
Patients with a history of upper extremity recent fracture, history of
any other neurological deficits, epilepsy, stroke, demyelinating
disorders, diabetes, migraine, headache, systemic disease, on
medications affecting CNS and cardiac pacemaker placement will be
excluded
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method